From: Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial
Time of sampling
Placebo (n = 91)
Azithromycin (n = 91)
Baseline
29/30 (96.7%)
24-month follow-up
61/61 (100.0%)
60/61 (98.4%)